Amdocs (DOX) reported $1.16 billion in revenue for the quarter ended December 2025, representing a year-over-year increase of 4.1%. EPS of $1.81 for the same period compares to $1.66 a year ago.
The reported revenue represents a surprise of +0.32% over the Zacks Consensus Estimate of $1.15 billion. With the consensus EPS estimate being $1.75, the EPS surprise was +3.28%.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how Amdocs performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Geographic Revenue- North America: $764.7 million versus the two-analyst average estimate of $768.4 million. The reported number represents a year-over-year change of +3.7%.
- Geographic Revenue- Rest of the World: $209.5 million compared to the $209.52 million average estimate based on two analysts. The reported number represents a change of -3.6% year over year.
- Geographic Revenue- Europe: $181.7 million versus the two-analyst average estimate of $175.12 million. The reported number represents a year-over-year change of +17.1%.
- Revenue- Managed Services Revenue: $745.9 million versus $759.34 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +2.3% change.
View all Key Company Metrics for Amdocs here>>>
Shares of Amdocs have remained unchanged over the past month versus the Zacks S&P 500 composite's +1.8% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Amdocs Limited (DOX): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
